The DCCC ctDNA Research Center support PhD projects focusing on documenting the positive effects of using ctDNA guidet cancer treatment. 

Since 2020, the DCCC ctDNA center has co-financed the following projects. 

OPTIMISE - OPTIMIzation of treatment SElection and follow up in oligometastatic colorectal cancer - a ctDNA guided phase II randomized approach. 
PhD student Louise Bach Callesen, AUH

DETECT - Early detection of lung cancer by blood samples - A prospective national observational study
PhD student Sara Witing Christensen Wen, Vejle Sygehus

CURE - Clinical Utility of circulating Tumor DNA in Gastro-Esophageal Cancer
PhD student Cecilie Riis Iden

CIRCPAC– A National Randomized Trial Investigating the Clinical Benefit of circulating tumor DNA Guided Recurrence Surveillance After Resection for Pancreatic Cancer
Julia Sidenius Johansen, Professor, MD, DMSc

Circulating tumor DNA for early detection of recurrence and risk-stratification in melanoma
Lisbet Rosenkrantz Hölmich, Professor, MD, DMSc

Early detection of treatment failure by circulating tumor DNA in advanced non-small cell lung cancer

Malene Støchkel Frank, Afdelingslæge, PhD student

Circulating tumor-DNA for the proper allocation of completion resection in early colorectal cancer

Mads Klein, Associate professor

Close monitoring of treatment response of patients with metastatic Non-Small Cell Lung cancer using liquid biopsy with focus on ctDNA methylation and ctRNA PD-L1 status

Christina Søs Audur Andersen, Molecular Biologist, PhD Student 

NOAC 9 - A Phase II Randomised Nordic Anal Cancer Group Study on Circulating Tumor DNA guided Follow-Up

Overlæge Professor, PhD Dr.med., Karen-Lise Spindler
Eksperimentel Klinisk Onkologi, AUH